Breaking News

Verily taps a Starbucks veteran to lead turnaround; bird flu experts see a familiar threat

February 8, 2023
Mike Reddy for STAT

STAT+ | Verily, struggling to turn profits, taps a Starbucks veteran and 'Warcraft' master

Stephen Gillett, the new CEO of Alphabet's Verily, now finds himself in charge of a high-profile effort to transform health care with tech.

By Casey Ross


Tracking the bird flu, experts see a familiar threat — and a virus whose course is hard to predict

A recent mink outbreak is concerning. But it's important to remember that we've been someplace like this before with this virus.

By Helen Branswell


STAT+ | CVS' Oak Street Health acquisition continues the industry's provider obsession

CVS Health's $10.6 billion acquisition of Oak Street Health plants another flag in the latest era of health insurance industry consolidation.

By Bob Herman and Tara Bannow



Bill Anderson will become the first American to run Bayer.
Bayer

STAT+ | Bayer, facing investor ire, appoints an outsider CEO

The company named former Roche executive Bill Anderson as its new CEO on Wednesday, potentially ending a dramatic and difficult chapter.

By Matthew Herper and Damian Garde


Opinion: Mr. President, health care has a data problem. 'Let's finish the job'

The lack of health care data interoperability is one of the most significant drivers of administrative waste in the U.S. health care system.

By Steven Lane


Seizure drug offers hope of expanding the pool of donor hearts

If supported by further trials, a new method could substantially increase the four-hour cap on storage time for a donor heart.

By Elaine Chen


Adobe

STAT+ | 5 health tech startups targeting chronic kidney disease to watch

There's been a surge in funding for health tech startups targeting chronic kidney disease. Here are five to watch.

By Ambar Castillo


Opinion: Pregnant people with substance use disorders need treatment, not criminalization

People with active substance use disorders during and after pregnancy need support, not barriers to treatment or criminalization.

By Nora D. Volkow


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.

No comments